| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/26/2009 | WO2009024571A1 Blood coagulation factor inhibitors |
| 02/26/2009 | WO2009023955A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/26/2009 | WO2009003493A3 Mhc multimers, methods for their generation, labeling and use |
| 02/26/2009 | WO2009002768A3 Liquid bandage |
| 02/26/2009 | WO2008152140A3 Recombinant transferrin mutants |
| 02/26/2009 | WO2008139207A3 Labelled hgf binding peptides for imaging |
| 02/26/2009 | WO2008135361A3 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof |
| 02/26/2009 | WO2008102144A3 Aqueous formulations |
| 02/26/2009 | WO2008090585A3 Soluble forms of inclusion complexes of histone deacetylase inhibitors and cyclodextrins, their preparation processes and uses in the pharmaceutical field |
| 02/26/2009 | WO2008045604A3 Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
| 02/26/2009 | WO2008037463A3 Means and methods of enhancing delivery to biological systems |
| 02/26/2009 | WO2008036117A3 Nanogel contrast agents for optical molecular imaging |
| 02/26/2009 | WO2008014060A3 Microparticle |
| 02/26/2009 | WO2008005458A3 Delivery device having self-assembling dendritic polymers and method of use thereof |
| 02/26/2009 | WO2007133908A3 Use of the irritating principal oleocanthal in olive oil, as well as structurally and functionally similar compounds |
| 02/26/2009 | WO2006083260A3 Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
| 02/26/2009 | US20090054590 drug polymer conjugates comprising biomaterials such as proteins linked through an activated moiety to a water soluble polyoxyethylene glycol derivatives |
| 02/26/2009 | US20090054537 Therapeutic protocols using hyaluronan |
| 02/26/2009 | US20090054536 palatable support of improved formula |
| 02/26/2009 | US20090054535 Method for embolization using liquid embolic materials |
| 02/26/2009 | US20090054533 Film coating compositions based on tribasic calcium phosphate |
| 02/26/2009 | US20090054368 Substituted gemini surfactant compounds |
| 02/26/2009 | US20090054364 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol |
| 02/26/2009 | US20090054343 Methods of therapy using pharmaceutical composition for thrombin peptide derivatives |
| 02/26/2009 | US20090054311 Novel Cyclosporin Analog Formulations |
| 02/26/2009 | US20090053313 Process for the preparation of a polymeric hydrogel based on a highly purified polyvinylalcohol and uses thereof |
| 02/26/2009 | US20090053290 Transdermal drug delivery compositions and topical compositions for application on the skin |
| 02/26/2009 | US20090053285 Medicament Carrier Composition and Method Of Forming A Film Therefrom |
| 02/26/2009 | US20090053268 Nanoparticle modified lubricants and waxes with enhanced properties |
| 02/26/2009 | US20090053254 Recombinant human alpha-fetoprotein as an immunosuppressive agent |
| 02/26/2009 | US20090053248 Compositions and methods for transepithelial molecular transport |
| 02/26/2009 | US20090053247 Biological materials and uses thereof |
| 02/26/2009 | US20090053190 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer |
| 02/26/2009 | US20090053169 Oligonucleotide Core Carrier Compositions for Delivery of Nucleic Acid-Containing Therapeutic Agents, Methods of Making and Using the Same |
| 02/26/2009 | US20090053163 Warming and nonirritating lubricant compositions and method of comparing irritation |
| 02/26/2009 | US20090053155 Cosmetic Compositions Containing Silicone/Organic Copolymer |
| 02/26/2009 | US20090053144 Reduction in bacterial colonization by administering bacteriophage compositions |
| 02/26/2009 | CA2842980A1 Collagen-containing cell carrier |
| 02/26/2009 | CA2734577A1 Inflammation-regulating compositions and methods |
| 02/26/2009 | CA2713185A1 Cationic alpha-amino acid-containing biodegradable polymer gene transfer compositions |
| 02/26/2009 | CA2697328A1 Antifungal composition |
| 02/26/2009 | CA2697093A1 Use of carbon nanotube for drug delivery |
| 02/26/2009 | CA2697044A1 Liposome formulations of boronic acid compounds |
| 02/26/2009 | CA2697042A1 Liposome compositions for in vivo administration of boronic acid compounds |
| 02/26/2009 | CA2696793A1 Novel preparation for external use |
| 02/26/2009 | CA2696699A1 Saccharide-containing protein conjugates and uses thereof |
| 02/26/2009 | CA2696632A1 High concentration local anesthetic formulations |
| 02/26/2009 | CA2696627A1 Psma binding ligand-linker conjugates and methods for using |
| 02/26/2009 | CA2696027A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 02/26/2009 | CA2695532A1 Polymeric linkers containing pyridyl disulfide moieties |
| 02/26/2009 | CA2691600A1 Hyaluronic acid injectable gel for treating joint degeneration |
| 02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
| 02/25/2009 | EP2027867A1 Method and composition for inhibition of tumor growth and enhancing an immune response |
| 02/25/2009 | EP2027865A1 Liposome having lipid membrane containing bacterial cell component |
| 02/25/2009 | EP2027851A1 Topical pharmaceutical formulations and methods of treatment |
| 02/25/2009 | EP2027850A1 Pharmaceutical compositions containing voriconazole |
| 02/25/2009 | EP2027849A1 External preparation for skin |
| 02/25/2009 | EP2027153A2 Dimeric molecular complexes |
| 02/25/2009 | EP2027145A1 A process for the preparation of poly-alfa-glutamic acid and derivatives thereof |
| 02/25/2009 | EP2026842A1 N-terminal modified peg-trail, method for preparing and uses thereof |
| 02/25/2009 | EP2026841A2 Conjugation process for pnag and a carrier protein |
| 02/25/2009 | EP2026840A2 Targeted imaging and/or therapy using the [3+2]-azide-alkyne cycloaddition |
| 02/25/2009 | EP2026838A2 A METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (hCG) VACCINE FOR LONG-ACTING ANTIBODY PRODUCTION |
| 02/25/2009 | EP2026823A2 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| 02/25/2009 | EP2026815A1 Controlled released preparations of oxcarbazepine having sigmoidal release profile |
| 02/25/2009 | EP2026789A2 Novel formulation, oriented to tumour physiology, of a cytostatic, in particular of cis-platinum |
| 02/25/2009 | EP2026770A1 Pharmaceutical formulations and compositions of a selective antagonist of either cxcr2 or both cxcr1 and cxcr2 and methods of using the same for treating inflammatory disorders |
| 02/25/2009 | EP1915128B1 Sterile, drop-forming, multi-phase, emulsifier-free ophthalmic product |
| 02/25/2009 | EP1758555B1 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 02/25/2009 | EP1753478B1 Medical device comprising a biologically active agent |
| 02/25/2009 | EP1474117B1 Composition for inhalation |
| 02/25/2009 | EP1448709B1 Method for preparing gels |
| 02/25/2009 | EP1439857B1 USE OF BISPECIFIC ANTIBODIES BINDING TO THE ACTIVATING RECEPTOR FcEpsilonRI AND TO THE INHIBITING RECEPTOR OX2Ra (CD200Ra) TO REGULATE IMMUNE RESPONSES |
| 02/25/2009 | EP1169050B1 Ocular treatment using cyclosporin-a derivatives |
| 02/25/2009 | CN101374554A Gelling hydrophobic injectable polymer compositions |
| 02/25/2009 | CN101374552A Medicine for transnasal administration |
| 02/25/2009 | CN101374536A Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 02/25/2009 | CN101374533A Use of selected lactic acid bacteria for reducing infantile colic |
| 02/25/2009 | CN101374531A Use of hyaluronic acid as a carrier molecule for different classes of therapeutic active agents |
| 02/25/2009 | CN101374529A Method of stabilizing s-adenosyl-l-methionine and stabilized composition |
| 02/25/2009 | CN101374505A Multiple unit type sustained release oral formulation and process for the preparation thereof |
| 02/25/2009 | CN101374504A Zaltoprofen-containing sustained release tablet and process for the preparation thereof |
| 02/25/2009 | CN101374503A Quickly disintegrating tablet produced by direct dry-tabletting |
| 02/25/2009 | CN101374500A Film-shaped drug forms for use in the oral cavity (wafers) |
| 02/25/2009 | CN101374499A Topical mecamylamine formulations for ocular administration and uses thereof |
| 02/25/2009 | CN101371933A Biodegradable hydrogel with temperature sensitivity and production method and use thereof |
| 02/25/2009 | CN101371925A Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof |
| 02/25/2009 | CN101371922A Water-bearing liquid transformation reaction vaccine formulation for oral mucous membrane administration |
| 02/25/2009 | CN101371920A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
| 02/25/2009 | CN101371917A Brain protein hydrolysate sodium chloride injection and preparation method thereof |
| 02/25/2009 | CN101371879A Aconitum sinomontanum transdermal paster and preparation method thereof |
| 02/25/2009 | CN101371877A Qi tian dropping pill extract and Qi tian dropping pill as well as method for producing the same |
| 02/25/2009 | CN101371844A Sticking tablet for curing mouth ulcer using mometasone furoate as active component |
| 02/25/2009 | CN101371842A Lornoxicam microsphere and preparation method thereof |
| 02/25/2009 | CN101371836A Paroxetine enteric sustained-release composition |
| 02/25/2009 | CN101371828A Hypocrellin liposome preparation and preparation method thereof |
| 02/25/2009 | CN101371824A Oral cavity pasting tablets using Methylprednisolone and derivatives thereof as active components |
| 02/25/2009 | CN101371820A Anticancer sustained-release agent containing methotrexate potentiating agent |
| 02/25/2009 | CN100463697C Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant external ointments |
| 02/25/2009 | CN100463678C Ifosfamide compositions for parenteral administration and a process for their preparation |